Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1345

Similar articles for PubMed (Select 22566286)

1.

Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.

Parikh PB, Jeremias A, Naidu SS, Brener SJ, Lima F, Shlofmitz RA, Pappas T, Marzo KP, Gruberg L.

Catheter Cardiovasc Interv. 2012 Sep 1;80(3):352-7. doi: 10.1002/ccd.23394. Epub 2012 May 4.

PMID:
22566286
2.

Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention.

Nikolsky E, Mehran R, Turcot D, Aymong ED, Mintz GS, Lasic Z, Lansky AJ, Tsounias E, Moses JW, Stone GW, Leon MB, Dangas GD.

Am J Cardiol. 2004 Aug 1;94(3):300-5.

PMID:
15276092
3.

Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry.

Tsai TT, Patel UD, Chang TI, Kennedy KF, Masoudi FA, Matheny ME, Kosiborod M, Amin AP, Messenger JC, Rumsfeld JS, Spertus JA.

JACC Cardiovasc Interv. 2014 Jan;7(1):1-9. doi: 10.1016/j.jcin.2013.06.016.

4.
5.

Chronic kidney disease and the risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents.

Miao Y, Yu-Jie Z, Zhi-Jian W, Dong-Mei S, Yu-Yang L, Ying-Xin Z, Fei G, Shi-Wei Y, De-An J.

Catheter Cardiovasc Interv. 2012 Sep 1;80(3):361-7. doi: 10.1002/ccd.23464. Epub 2012 Mar 14.

PMID:
22419375
6.

Effects of statin treatment in patients with coronary artery disease and chronic kidney disease.

Kaneko H, Yajima J, Oikawa Y, Tanaka S, Fukamachi D, Suzuki S, Sagara K, Otsuka T, Matsuno S, Funada R, Kano H, Uejima T, Koike A, Nagashima K, Kirigaya H, Sawada H, Aizawa T, Yamashita T.

Heart Vessels. 2014 Jan;29(1):21-8. doi: 10.1007/s00380-013-0325-2. Epub 2013 Feb 21.

7.

The impact of renal function on the long-term clinical course of patients who underwent percutaneous coronary intervention.

Papafaklis MI, Naka KK, Papamichael ND, Kolios G, Sioros L, Sclerou V, Katsouras CS, Michalis LK.

Catheter Cardiovasc Interv. 2007 Feb 1;69(2):189-97.

PMID:
17253600
8.

The adverse long-term impact of renal impairment in patients undergoing percutaneous coronary intervention in the drug-eluting stent era.

Appleby CE, Ivanov J, Lavi S, Mackie K, Horlick EM, Ing D, Overgaard CB, Seidelin PH, von Harsdorf R, Dzavík V.

Circ Cardiovasc Interv. 2009 Aug;2(4):309-16. doi: 10.1161/CIRCINTERVENTIONS.108.828954. Epub 2009 Jun 30.

9.
10.

Decline in 20-year mortality after myocardial infarction in patients with chronic kidney disease: evolution from the prethrombolysis to the percutaneous coronary intervention era.

Nauta ST, van Domburg RT, Nuis RJ, Akkerhuis M, Deckers JW.

Kidney Int. 2013 Aug;84(2):353-8. doi: 10.1038/ki.2013.71. Epub 2013 Mar 13.

PMID:
23486524
11.

Differential survival after coronary revascularization procedures among patients with renal insufficiency.

Szczech LA, Reddan DN, Owen WF, Califf R, Racz M, Jones RH, Hannan EL.

Kidney Int. 2001 Jul;60(1):292-9.

12.

Short- and long-term outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic kidney disease.

Ashrith G, Lee VV, Elayda MA, Reul RM, Wilson JM.

Am J Cardiol. 2010 Aug 1;106(3):348-53. doi: 10.1016/j.amjcard.2010.03.037. Epub 2010 Jun 18.

PMID:
20643244
13.

Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator.

Zishiri ET, Williams S, Cronin EM, Blackstone EH, Ellis SG, Roselli EE, Smedira NG, Gillinov AM, Glad JA, Tchou PJ, Szymkiewicz SJ, Chung MK.

Circ Arrhythm Electrophysiol. 2013 Feb;6(1):117-28. doi: 10.1161/CIRCEP.112.973552. Epub 2012 Dec 28.

14.

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).

Marui A, Kimura T, Nishiwaki N, Mitsudo K, Komiya T, Hanyu M, Shiomi H, Tanaka S, Sakata R; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators.

Am J Cardiol. 2014 Aug 15;114(4):555-61. doi: 10.1016/j.amjcard.2014.05.034. Epub 2014 Jun 6.

PMID:
24996550
15.

The impact of previous revascularization on clinical outcomes in patients undergoing primary percutaneous coronary intervention.

Bench TJ, Parikh PB, Jeremias A, Brener SJ, Naidu SS, Shlofmitz RA, Pappas T, Marzo KP, Gruberg L.

J Invasive Cardiol. 2013 Apr;25(4):166-9.

16.

Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction and chronic kidney disease undergoing percutaneous coronary intervention.

Hanna EB, Chen AY, Roe MT, Wiviott SD, Fox CS, Saucedo JF.

JACC Cardiovasc Interv. 2011 Sep;4(9):1002-8. doi: 10.1016/j.jcin.2011.05.022.

17.

Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries.

Yan BP, Clark DJ, Buxton B, Ajani AE, Smith JA, Duffy SJ, Shardey GC, Skillington PD, Farouque O, Yii M, Yap CH, Andrianopoulos N, Brennan A, Dinh D, Reid CM; Australasian Society of Cardiac and Thoracic Surgeons (ASCTS); Melbourne Interventional Group (MIG).

Heart Lung Circ. 2009 Jun;18(3):184-90. doi: 10.1016/j.hlc.2008.10.005. Epub 2009 Mar 5.

PMID:
19268632
18.

Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease.

Reddan DN, Szczech LA, Tuttle RH, Shaw LK, Jones RH, Schwab SJ, Smith MS, Califf RM, Mark DB, Owen WF Jr.

J Am Soc Nephrol. 2003 Sep;14(9):2373-80.

19.

Outcomes in patients with renal impairment undergoing percutaneous coronary intervention and implantation of the Endeavor zotarolimus-eluting stent: 1- and 2-year data from the E-Five Registry.

Rothman MT, Jain AK; E-Five Registry Investigators.

Catheter Cardiovasc Interv. 2012 Nov 15;80(6):885-92. doi: 10.1002/ccd.23484. Epub 2012 Apr 19.

PMID:
22517785
20.

Incidence and impact on prognosis of bleeding during percutaneous coronary interventions in patients with chronic kidney disease.

Ndrepepa G, Neumann FJ, Cassese S, Fusaro M, Ott I, Schulz S, Hoppmann P, Richardt G, Laugwitz KL, Schunkert H, Kastrati A.

Clin Res Cardiol. 2014 Jan;103(1):49-56. doi: 10.1007/s00392-013-0622-x. Epub 2013 Oct 4.

PMID:
24092474
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk